John Edward Robinson

Executive

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 1 saleJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€3.0M

Latest filing published 30 Dec 2025 for Cogent Biosciences, Inc., €3.0M. Read the official filing

Filing timeline

BuySale

John Edward Robinson

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

John Edward Robinson: trading record in brief

John Edward Robinson is a declared insider of Cogent Biosciences, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 17 December 2025 to 26 December 2025, the count stands at 2 filings.

No open-market purchase appears, only 1 sale worth €3.0M. The rest of the record consists of 1 share grant.

On 30 December 2025 came the latest disclosure, an open-market sale for €3.0M in Cogent Biosciences, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.